↓ Skip to main content

Serum Pepsinogen as a Biomarker for Gastric Cancer in the United States: A Nested Case-Control Study Using the PLCO Cancer Screening Trial Data.

Overview of attention for article published in Cancer Epidemiology, Biomarkers & Prevention, May 2022
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (82nd percentile)
  • High Attention Score compared to outputs of the same age and source (83rd percentile)

Mentioned by

news
1 news outlet
twitter
2 X users

Citations

dimensions_citation
9 Dimensions

Readers on

mendeley
17 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Serum Pepsinogen as a Biomarker for Gastric Cancer in the United States: A Nested Case-Control Study Using the PLCO Cancer Screening Trial Data.
Published in
Cancer Epidemiology, Biomarkers & Prevention, May 2022
DOI 10.1158/1055-9965.epi-21-1328
Pubmed ID
Authors

Haejin In, Srawani Sarkar, Jessica Ward, Patricia Friedmann, Michael Parides, Julie Yang, Meira Epplein

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 17 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 17 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 2 12%
Researcher 2 12%
Student > Ph. D. Student 2 12%
Other 1 6%
Professor 1 6%
Other 2 12%
Unknown 7 41%
Readers by discipline Count As %
Medicine and Dentistry 6 35%
Agricultural and Biological Sciences 1 6%
Nursing and Health Professions 1 6%
Unknown 9 53%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 10. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 26 July 2022.
All research outputs
#3,564,161
of 25,392,582 outputs
Outputs from Cancer Epidemiology, Biomarkers & Prevention
#1,012
of 4,850 outputs
Outputs of similar age
#77,536
of 445,421 outputs
Outputs of similar age from Cancer Epidemiology, Biomarkers & Prevention
#10
of 59 outputs
Altmetric has tracked 25,392,582 research outputs across all sources so far. Compared to these this one has done well and is in the 85th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 4,850 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 16.4. This one has done well, scoring higher than 78% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 445,421 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 82% of its contemporaries.
We're also able to compare this research output to 59 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 83% of its contemporaries.